Surgery Partners, Inc.
Close on Oct 19, 2026
- Market cap
- $1.90B
- P/E (TTM)
- –
- Dividend yield
- –
Earnings
Next report expected Nov 9, 2026, before market open (estimated from past report dates)
| Quarter | Reported | Time | Revenue | EPS (GAAP) | EPS (adjusted) |
|---|---|---|---|---|---|
| Q2 FY2026 Ended Jun 30, 2026 | Aug 10, 2026 | Before market open | $848.90M | $-0.12 | $0.10 |
| Q1 FY2026 Ended Mar 31, 2026 | May 5, 2026 | Before market open | $810.90M | $-0.28 | $-0.03 |
| Q4 FY2025 Ended Dec 31, 2025 | Mar 2, 2026 | After market close | $885.00M | $-0.12 | $0.12 |
| Q3 FY2025 Ended Sep 30, 2025 | Nov 10, 2025 | Before market open | $821.50M | $-0.18 | $0.13 |
| Q2 FY2025 Ended Jun 30, 2025 | Aug 5, 2025 | Before market open | $826.20M | $-0.02 | $0.17 |
| Q1 FY2025 Ended Mar 31, 2025 | May 12, 2025 | Before market open | $776.00M | $-0.30 | $0.04 |
| Q4 FY2024 Ended Dec 31, 2024 | Mar 3, 2025 | Before market open | $864.40M | $-0.86 | $0.44 |
| Q3 FY2024 Ended Sep 30, 2024 | Nov 12, 2024 | Before market open | $770.40M | $-0.25 | $0.19 |
| Q2 FY2024 Ended Jun 30, 2024 | Aug 6, 2024 | Before market open | – | – | – |
| Q1 FY2024 Ended Mar 31, 2024 | May 7, 2024 | Before market open | – | – | – |
| Q4 FY2023 Ended Dec 31, 2023 | Feb 26, 2024 | Before market open | – | – | – |
Company guidance
Outlook given with results on Aug 10, 2026, compared with the previous outlook
| Measure | Period | Guidance | vs. prior |
|---|---|---|---|
| Adjusted EBITDAnon-GAAP | Full year 2026 | $530.00M | Maintained |
| revenue | Full year 2026 | $3.35B to $3.45B | Maintained |
Figures and the sentence they come from are taken from the company's earnings release. Hover a measure to read the source sentence.
Press releases
Announcements Surgery Partners filed with the SEC
SURGERY PARTNERS, INC. ANNOUNCES SECOND QUARTER 2026 RESULTS
Results of operations · EX-99.1 to Form 8-K
2nd Quarter 2026 Earnings Presentation August 10, 2026
Results of operations · EX-99.2 to Form 8-K
Surgery Partners Announces Entry Into Agreement to Sell Ownership Interests in Idaho Falls Facilities to Intermountain Health; Reaffirms Guidance, Excluding Impact of Transaction
Material agreement · Regulation FD disclosure · EX-99.1 to Form 8-K
SURGERY PARTNERS, INC. ANNOUNCES FIRST QUARTER 2026 RESULTS
Results of operations · EX-99.1 to Form 8-K
1st Quarter 2026 Earnings Presentation May 5, 2026
Results of operations · EX-99.2 to Form 8-K
SURGERY PARTNERS, INC. ANNOUNCES FOURTH QUARTER AND
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
4th Quarter 2025 Earnings Presentation March 3, 2026
Results of operations · Regulation FD disclosure · EX-99.2 to Form 8-K
SURGERY PARTNERS, INC. ANNOUNCES PRICING OF
Other events · EX-99.1 to Form 8-K
SURGERY PARTNERS, INC. ANNOUNCES ADD-ON SENIOR
Regulation FD disclosure · EX-99.1 to Form 8-K
SURGERY PARTNERS, INC. ANNOUNCES THIRD QUARTER 2025 RESULTS
Results of operations · EX-99.1 to Form 8-K
SURGERY PARTNERS, INC. ANNOUNCES SECOND QUARTER 2025 RESULTS
Results of operations · EX-99.1 to Form 8-K
SURGERY PARTNERS, INC. and Bain Capital Conclude Discussions
Regulation FD disclosure · EX-99.1 to Form 8-K
SURGERY PARTNERS, INC. ANNOUNCES FIRST QUARTER 2025 RESULTS
Results of operations · EX-99.1 to Form 8-K
SURGERY PARTNERS, INC. ANNOUNCES FOURTH QUARTER AND
Results of operations · EX-99.1 to Form 8-K
Partners, Inc. Confirms Receipt of Non-Binding Acquisition Proposal from Bain Capital
Other events · EX-99.1 to Form 8-K
SURGERY PARTNERS, INC. ANNOUNCES THIRD QUARTER 2024 RESULTS
Results of operations · EX-99.1 to Form 8-K
SURGERY PARTNERS, INC. ANNOUNCES SECOND QUARTER 2024 RESULTS
Results of operations · EX-99.1 to Form 8-K
SURGERY PARTNERS, INC. ANNOUNCES FIRST QUARTER 2024 RESULTS
Results of operations · EX-99.1 to Form 8-K
SURGERY PARTNERS, INC. ANNOUNCES PRICING OF NEW SENIOR NOTES OFFERING
Other events · EX-99.1 to Form 8-K
SURGERY PARTNERS, INC. ANNOUNCES NEW SENIOR NOTES OFFERING
Regulation FD disclosure · EX-99.1 to Form 8-K
SURGERY PARTNERS, INC. ANNOUNCES FOURTH QUARTER AND FULL YEAR 2023 RESULTS; SETS 2024 GUIDANCE
Results of operations · EX-99.1 to Form 8-K
Information Relating to Part II.
Material agreement · Other events · EX-99.1 to Form 8-K
SURGERY PARTNERS, INC. COMPLETES REFINANCING TRANSACTION
Regulation FD disclosure · EX-99.1 to Form 8-K
SURGERY PARTNERS, INC. ANNOUNCES THIRD QUARTER 2023 RESULTS
Results of operations · EX-99.1 to Form 8-K
SURGERY PARTNERS, INC. ANNOUNCES SECOND QUARTER 2023 RESULTS
Results of operations · EX-99.1 to Form 8-K
SURGERY PARTNERS, INC. ANNOUNCES FIRST QUARTER 2023 RESULTS
Results of operations · EX-99.1 to Form 8-K
SURGERY PARTNERS, INC. ANNOUNCES FOURTH QUARTER AND FULL YEAR 2022 RESULTS; SETS 2023 GUIDANCE
Results of operations · EX-99.1 to Form 8-K
SURGERY PARTNERS, INC. ANNOUNCES THIRD QUARTER 2022 RESULTS
Results of operations · EX-99.1 to Form 8-K
SURGERY PARTNERS, INC. ANNOUNCES SECOND QUARTER 2022 RESULTS
Results of operations · EX-99.1 to Form 8-K
SURGERY PARTNERS, INC. ANNOUNCES FIRST QUARTER 2022 RESULTS
Results of operations · EX-99.1 to Form 8-K
SURGERY PARTNERS, INC. ANNOUNCES FOURTH QUARTER AND FULL YEAR 2021 RESULTS; RAISES 2022 GUIDANCE
Results of operations · EX-99.1 to Form 8-K
SURGERY PARTNERS REAFFIRMS 2021 AND 2022 FULL YEAR GUIDANCE; DAVID T. DOHERTY TO ASSUME ROLE OF CHIEF FINANCIAL OFFICER ON FEBRUARY 1, 2022
Results of operations · Executive or director change · EX-99.1 to Form 8-K
SURGERY PARTNERS, INC. ANNOUNCES THIRD QUARTER 2021 RESULTS
Results of operations · EX-99.1 to Form 8-K